Status:
WITHDRAWN
Polyethylene Glycol to Improve Sensation Following Digital Nerve Laceration
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Peripheral Nerve Injury
Nerve Injury
Eligibility:
All Genders
16-120 years
Phase:
PHASE1
PHASE2
Brief Summary
PEG is a fusogen, a type of chemical that aids in mediating cell fusion. PEG helps nerve cells recover neuronal continuity by removing plasmalemmal-bound water which opens the axonal ends on both side...
Eligibility Criteria
Inclusion
- (1) surgery within twenty-four hours of injury (2) surgery completed in the minor procedures unit of the Halifax Infirmary.
Exclusion
- (1) patients with cognitive impairment
Key Trial Info
Start Date :
June 26 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04270019
Start Date
June 26 2020
End Date
September 15 2023
Last Update
January 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.